We show here that NgR2 promotes NED, tumor growth, as well as a motile phenotype of PrCa cells; these findings are novel because NgR2 has minimally been investigated in cancer34 and has instead been predominantly analyzed in neuroscience studies. Here, RTN4RL2 is linked to neoplasm.